VTRS 📈 Viatris - Overview

Viatris Inc. is a global healthcare company that operates across four distinct segments: Developed Markets, Greater China, JANZ, and Emerging Markets. This strategic segmentation enables the company to cater to diverse patient needs, regulatory requirements, and market dynamics. The company's product portfolio is extensive, comprising prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). These offerings span various therapeutic areas, including noncommunicable and infectious diseases, with a focus on biosimilars in areas like oncology, immunology, and endocrinology.

The company's API offerings are equally diverse, covering antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas. To support patients in managing their health, Viatris provides a range of services, including diagnostic clinics, educational seminars, and digital tools. Its medicines are available in various forms, such as oral solid doses, injectables, complex dosage forms, and APIs, which are distributed to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. This multi-channel approach ensures that its products reach a wide audience, including those in remote or underserved areas.

Viatris has established a robust distribution network, leveraging partnerships with pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company's product lineup includes well-known brands like Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri, as well as Norvasc, Viagra, AMITIZA, Lipacreon, Effexor, Celebrex, and ARV names, including glargine and SEMGLEE. To further enhance its offerings, Viatris has entered into collaboration and licensing agreements with companies like Revance Therapeutics, Inc. and Momenta Pharmaceuticals, Inc. With a history dating back to 1961, Viatris Inc. is headquartered in Canonsburg, Pennsylvania, and its common stock is listed on the NASDAQ under the ticker symbol VTRS.

As a major player in the pharmaceutical industry, Viatris is committed to improving access to healthcare and making a positive impact on the lives of patients worldwide. With its global presence, diverse product portfolio, and commitment to innovation, the company is well-positioned to address the evolving needs of the healthcare landscape. Through its website, https://www.viatris.com, Viatris provides stakeholders with access to information on its products, services, and initiatives, as well as its financial performance and corporate governance. With an ISIN of US92556V1061 and a classification as a common stock in the GICS Sub Industry: Pharmaceuticals, Viatris Inc. is a significant entity in the global pharmaceutical sector.